Katherine E. Bliss

3 weeks ago | csis.org | Jirair Ratevosian |J. Stephen Morrison |Katherine E. Bliss

On January 20, President Trump announced a 90-day review of U.S. foreign assistance, which was later extended to 120 days. The review, which is set to conclude in the third week of May, was supposed to cover a wide range of development and global health programs, including the President’s Emergency Plan for AIDS Relief (PEPFAR).

Jan 31, 2025 | csis.org | J. Stephen Morrison |Katherine E. Bliss

A Need for Fresh ThinkingImperiled health is the human face of climate change. Indeed, the climate crisis is increasingly recognized to be a health crisis. It is a crisis marked by higher mortality, costly illnesses, and increased risks of new biological pathogens that together threaten U.S. national security interests. The most visible climate-related factors endangering health are dangerous forms of heat, along with wildfires and smoke, as well as ferocious storms and floods.

Dec 2, 2024 | csis.org | Katherine E. Bliss

More than two decades since the launch of global programs dedicated to bringing prevention, diagnostic, and treatment services to people at risk of, or living with, human immunodeficiency virus (HIV), the international commitment to end HIV as a public health threat by 2030 is at a critical juncture.

Oct 22, 2024 | csis.org | Erin Murphy |Katherine E. Bliss |J. Stephen Morrison

The Quad heads of state from Australia, the United States, Japan, and India committed—to the surprise of many observers—to the Quad Cancer Moonshot Initiative during their summit in Wilmington, Delaware, on September 21. The collective goal of this ambitious effort is to advance the elimination of cervical cancer, caused by the human papillomavirus (HPV), in collaboration with low- and middle-income Indo-Pacific partners, through expanded access to vaccines, screening, and treatment.

Oct 18, 2024 | features.csis.org | Katherine E. Bliss

By Katherine Bliss | October 18, 2024 Over the last century, the quest to control and eliminate malaria—a debilitating, deadly, and costly disease transmitted by mosquitoes—has challenged governments, international organizations, and public health researchers. Substantial investments in research and development have led to new diagnostic tools and treatments that have successfully reduced the number of deaths from malaria since the early 2000s.